Your Source for BioScience Venture Capital Data
  • SEARCH THE OnBioVC DATABASE:

  • OnBioVC NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • Photobucket

  • FDA Registered Contract Manufacturer

Sequent Medical (Aliso Viejo, CA) a commercial-stage medical device company focused on endovascular embolic coils devices for ruptured and non-ruptured intracranial aneurysms, closed a $26M Series C financing. Participants include Delphi Ventures, Versant Ventures, US Venture Partners and Domain Associates. Note: Closing out 1Q deals. Thanx for your patience as we play catch-up.

Sensors for Medicine and Science (Germantown, MD) a commercial-stage device company focused on implantable, long- term continuous glucose monitoring, closed a $54.1M million in Series D financing. Participants include Delphi Ventures, New Enterprise Associates, HealthCare Ventures, Anthem Capital and Greenspring Associates.

Pivot Medical (Sunnyvale, CA) a clinical-stage device company focused on minimally invasive hip restoration technologies, closed a $32M Series C financing. Participants include Adams Street Partners, Delphi Ventures, Montreux Equity Partners and Ivy Capital Partners.

Aegea Medical (Redwood City, CA) a development-stage medical device company focused on a minimally invasive treatment for abnormal uterine bleeding, closed a $13.3M Series B financing. Participants include Covidien Ventures, Alloy Ventures and Delphi Ventures.

Cameron Health (San Clemente, CA) a commercial-stage medical device company focused on a subcutaneous implantable defibrillator platform, closed a $107M Series E financing. Participants include Alloy Ventures and Delphi Ventures.

PixelOptics (Roanoke, VA) a commercial-stage developer of dynamic electronic focusing eyeglasses, closed a $35M Series D financing. Participants include Safeguard Scientifics, Delphi Ventures, Carlyle Group, Longitude Capital and Stark Investments.

Relypsa (Santa Clara, CA) a clinical-stage developer of a therapeutic for hyperkalemia in congestive heart failure patients, closed a $70M Series B financing. Participants include 5AM Ventures, New Leaf Partners, Delphi Ventures and OrbiMed Advisors.

BarRx Medical (Sunnyvale, CA) a clinical-stage medical device company focused on endoscopic treatment of precancerous lesions of the esophagus and other chronic gastrointestinal diseases, closed a $15M Series financing. Participants include Highland Capital Partners, Delphi Ventures, Alloy Ventures, Frazier Healthcare Ventures, Sutter Hill Ventures and Greenspring Associates.

TriVascular (Santa Rosa, CA) a commercial-stage medical device company focused on endovascular repair devices for the treatment of abdominal aortic aneurysms, closed a $60M Series C financing. Participants include Pinnacle Ventures, New Enterprise Associates, Delphi Ventures, MPM Capital and Kearny Venture Partners.

Calithera Biosciences (San Francisco, CA) a preclinical-stage small molecule company focused on caspase activators for oncologic applications, closed a $40M Series A financing. Participants include Morgenthaler Ventures, U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital.

Anulex Technologies (Minnetonka, MN) a commercial-stage medical device company focused on herniated discectomy procedures, closed a $18.3M Series E financing. Participants include Hatteras Late Stage VC Fund, Affinity Capital, Delphi Ventures, MB Venture Partners, New Enterprise Associates, SightLine Partners and Split Rock Partners.

Breathe Technologies (San Ramon, CA) a commercial-stage medical device company focused on therapeutic respiratory systems for the treatment of COPD and sleep apnea, closed a $23M Series C financing. Participants include DAG Ventures, Kleiner Perkins Caufield & Byers, Delphi Ventures, Synergy Ventures and Johnson & Johnson Development Corp..

Astute Medical (San Diego, CA) a development-stage diagnostic company focused on the identification and validation of protein biomarkers that can test for hospital acquired acute conditions like sepsis, kidney injury and abdominal pain, closed a $26.5M Series B financing. Participants include Domain Associates, Delphi Ventures, Johnson & Johnson Development Corp. and De Novo Ventures.

« Previous Entries  Next Page »

to top of page...